939 related articles for article (PubMed ID: 1645456)
1. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and processing of the type II insulin-like growth factor receptor in H-35 hepatoma cells.
MacDonald RG; Czech MP
J Biol Chem; 1985 Sep; 260(20):11357-65. PubMed ID: 2993308
[TBL] [Abstract][Full Text] [Related]
3. Post-translational processing and activation of insulin and EGF proreceptors.
Lane MD; Ronnett G; Slieker LJ; Kohanski RA; Olson TL
Biochimie; 1985; 67(10-11):1069-80. PubMed ID: 3000457
[TBL] [Abstract][Full Text] [Related]
4. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes.
MacDonald RG
Endocrinology; 1991 Jan; 128(1):413-21. PubMed ID: 1846107
[TBL] [Abstract][Full Text] [Related]
5. Characterization of insulin-like growth factor-binding proteins from sheep thyroid cells.
Bachrach LK; Liu FR; Burrow GN; Eggo MC
Endocrinology; 1989 Dec; 125(6):2831-8. PubMed ID: 2479527
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1,4,5-trisphosphate formation.
Guse AH; Kiess W; Funk B; Kessler U; Berg I; Gercken G
Endocrinology; 1992 Jan; 130(1):145-51. PubMed ID: 1309323
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor II/mannose-6-phosphate receptor is present in fetal and maternal sheep serum.
Gelato MC; Rutherford C; Stark RI; Daniel SS
Endocrinology; 1989 Jun; 124(6):2935-43. PubMed ID: 2542005
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor-II (IGF II) receptor from rat brain is of lower apparent molecular weight than the IGF II receptor from rat liver.
McElduff A; Poronnik P; Baxter RC
Endocrinology; 1987 Oct; 121(4):1306-11. PubMed ID: 2958268
[TBL] [Abstract][Full Text] [Related]
9. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor.
Kiess W; Thomas CL; Greenstein LA; Lee L; Sklar MM; Rechler MM; Sahagian GG; Nissley SP
J Biol Chem; 1989 Mar; 264(8):4710-4. PubMed ID: 2538455
[TBL] [Abstract][Full Text] [Related]
11. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
12. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line.
Park JH; Vanderhoof JA; Blackwood D; Macdonald RG
Endocrinology; 1990 Jun; 126(6):2998-3005. PubMed ID: 2161743
[TBL] [Abstract][Full Text] [Related]
13. Identification and in situ localization of the insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptor in the rat gastrointestinal tract: comparison with the IGF-I receptor.
Heinz-Erian P; Kessler U; Funk B; Gais P; Kiess W
Endocrinology; 1991 Oct; 129(4):1769-78. PubMed ID: 1655382
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling.
Kusui T; Benya RV; Battey JF; Jensen RT
Biochemistry; 1994 Nov; 33(44):12968-80. PubMed ID: 7947701
[TBL] [Abstract][Full Text] [Related]
15. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
16. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Nakazima Y; Akiyama S
Biochim Biophys Acta; 1991 Mar; 1073(2):309-15. PubMed ID: 1672608
[TBL] [Abstract][Full Text] [Related]
18. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
19. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.
Rosenfeld RG; Ceda G; Cutler CW; Dollar LA; Hoffman AR
Endocrinology; 1985 Nov; 117(5):2008-16. PubMed ID: 2995005
[TBL] [Abstract][Full Text] [Related]
20. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
Hawkins LK; Wold WS
Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
